Intussusception is the process by which one segment of intestine “telescopes” into another segment. Escherichia coli O157:H7 is a rare cause of intussusception that uncommonly requires a surgical procedure.
Methods:
Case report and literature review.
Results:
We reviewed 25 cases of infection with E. coli O157:H7 that resulted in intussusception, all of which involved minors. Our case identifies the first reported adult with intussusception secondary to E. coli infection necessitating surgical intervention. In total, two (8%) required operation. Hemolytic uremic syndrome did not develop in any patient, and there were no deaths.
Conclusions:
E. coli O157:H7-associated intussusception is rare and does not commonly require operation. If conservative management fails, a surgical procedure may be necessary to resect the pathologic lead point.
Get full access to this article
View all access options for this article.
References
1.
LloydDA, KennySE. The surgical abdomen. In: WalkerWA, GouletO, KleinmanRE, et al. (eds). Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management, 4th ed. Ontario: BC Decker, 2004:604.
2.
BuettcherM, BaerG, BonhoefferJ, et al.Three-year surveillance of intussusception in children in Switzerland. Pediatrics, 2007; 120:473–480.
3.
Yap ShiyiE, GanapathyS. Intussusception in children presenting to the emergency department: An Asian perspective. Pediatr Emerg Care, 2017; 33:409–413.
4.
MarinisA, YiallourouA, SamanidesL, et al.Intussusception of the bowel in adults: A review. World J Gastroenterol, 2009; 15:407–411.
5.
NtouliaA, TharakanSJ, ReidJR, MahboubiS. Failed intussusception reduction in children: Correlation between radiologic, surgical, and pathologic findings. AJR Am J Roentgenol, 2016; 207:424–433.
6.
ErkanN, HaciyanliM, YildirimM, et al.Intussusception in adults: An unusual and challenging condition for surgeons. Int J Colorectal Dis, 2005; 20:452–456.
7.
LinXK, XiaQZ, HuangXZ, et al.Clinical characteristics of intussusception secondary to pathologic lead points in children: A single-center experience with 65 cases. Pediatr Surg Int, 2017; 33:793–797.
8.
NylundCM, DensonLA, NoelJM. Bacterial enteritis as a risk factor for childhood intussusception: A retrospective cohort study. J Pediatr, 2010; 156:761–765.
9.
FletcherS, SibbrittD, StarkD, et al.Descriptive epidemiology of infectious gastrointestinal illnesses in Sydney, Australia, 2007–2010. Western Pac Surveill Response J, 2015; 6:7–16.
10.
SkirrowMB. A demographic survey of campylobacter, salmonella and shigella infections in England. A Public Health Laboratory Service Survey. Epidemiol Infect, 1987; 99:647–657.
11.
HashimotoR, YamamotoY, TanumaT. An unusual cause of intussusception. J Gastrointestin Liver Dis, 2015; 24:412.
12.
HagiwaraS, TobayamaH, KagimotoS. Successful colonoscopic approach in a child with intussusception associated with enterohemorrhagic Escherichia coli O157 infection. Pediatr Rep, 2012; 4:e33.
FukushimaH, HashizumeT, MoritaY, et al.Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996. Pediatr Int, 1999; 41:213–217.
15.
LopezEL, DevotoS, WolojM, et al.Intussusception associated with Escherichia coli O157:H7. Pediatr Infect Dis J, 1989; 8:471–473.
16.
RileyLW, RemisRS, HelgersonSD, et al.Hemorrhagic colitis associated with a rare Eschrichia coli serotype. N Engl J Med, 1983; 308:681–685.
17.
RangelJM, SparlingPH, CroweC, et al.Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982–2002. Emerg Infect Dis, 2005; 11:603–609.
18.
ArbizuRA, AljomahG, KozielskiR, et al.Intussusception associated with adenovirus. J Pediatr Gastroenterol Nutr, 2014; 59:e41.
19.
PerrinWS, LindsayEC. Intussusception: A monograph based on 400 cases. Br J Surg, 1921; 9:46–71.
20.
LinZ, CohenP, NissanA, et al.Bacterial wall lipopolysaccharide as a cause of intussusception in mice. J Pediatr Gastroenterol Nutr, 1998; 27:301–305.
21.
KeenanKP, SharpnackDD, CollinsH, et al.Morphologic evaluation of the evaluation of shigatoxin and E. coli Shiga-like toxin on the rabbit intestine. Am J Pathol, 1986; 125:69–80.
22.
MoyerMP, DixonPS, RothamSW, BrownJE. Cytotoxicity of Shiga toxin for primary cultures of human colonic and epithelial cells. Infect Immun, 1987; 55:1533–1535.
23.
JohnsonKE, ThorpeCM, SearsCL. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin Infect Dis, 2006; 43:1587–1595.
24.
BellBP, GriffinPM, LozanoP, et al.Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics, 1997; 100:E12.
25.
FreedmanSB, XieJ, NeufeldMS, et al.Shiga toxin-producing Escherichia coli infection, antibiotics, and risk of developing hemolytic uremic syndrome: A meta-analysis. Clin Infect Dis, 2016; 62:1251–1258.
26.
SuC, BrandtLJ. Escherichia coli O157:H7 infection in humans. Ann Intern Med, 1995; 123:698–714.
27.
WatersJR, SharpJC, DevVJ. Infection caused by Escherichia coli O157:H7 in Alberta, Canada, and in Scotland: A five-year review, 1987–1991. Clin Infect Dis, 1994; 19:834–843.
